A detailed history of Bvf Inc transactions in Gh Research PLC stock. As of the latest transaction made, Bvf Inc holds 10,400,158 shares of GHRS stock, worth $72.8 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares
10,400,158
Previous 10,400,158 -0.0%
Holding current value
$72.8 Million
Previous $121 Million 42.62%
% of portfolio
2.21%
Previous 3.71%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$5.26 - $11.04 $5.92 Million - $12.4 Million
1,125,000 Added 12.13%
10,400,158 $60.3 Million
Q3 2021

Nov 15, 2021

BUY
$16.51 - $23.68 $33 - $47
2 Added 0.0%
9,275,158 $205 Million
Q2 2021

Aug 16, 2021

BUY
$19.25 - $21.73 $179 Million - $202 Million
9,275,156 New
9,275,156 $202 Million

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $364M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.